Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
59.00    2.50 (4.42%)
Bid:
58.00
Ask:
60.00
Spread: 2.00 (3.448%)
Market Cap: £55.91m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Trading update

9 May 2019 07:00

RNS Number : 4355Y
Panoply Holdings PLC (The)
09 May 2019
 

9 May 2019

The Panoply Holdings PLC

("The Panoply", or the "Group")

Trading update

The Panoply, a digitally native technology services company, today announces a trading update for the year ended 31 March 2019 ("FY19").

The Board is pleased to announce that it expects to report revenue and EBITDA performance in line with expectations when it publishes its maiden full year results, following its successful IPO and Admission to trading on AIM in December 2018. This performance has been driven by an increase in customer numbers across its constituent companies and particularly from work in the government and not-for-profit sectors. At the year end the Group had net cash* of £4.9 million.

Since the Group's IPO, a further three acquisitions have been concluded and the relevant integration of those businesses largely completed. Investments have also been made into new business units which complement and expand the Group's existing services and expertise, and which can generate future revenue streams, including TPX human+ which was launched at the end of February.

Neal Gandhi, CEO of The Panoply, stated:

"I'm delighted with the progress that we have made in the year. The IPO was clearly the most significant milestone as it brought together four outstanding companies, ideally placed to manage the digital transformation needs of today's world, and provided us with the platform to attract other, like minded visionary companies. It has been particularly pleasing to witness the high levels of collaboration across the business units as they each strive to maximise opportunities for the wider Group.

"With a healthy pipeline of potential acquisition opportunities and as our investment opportunities develop further, we look forward to the future with confidence."

* net cash is cash at bank (£5.6m) less consideration payments to be made in connection with acquisitions made by the Group (£700k)

Enquiries:

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited

(Nomad and Broker)

 

Via Alma PR

 

 

+44 (0)207 710 7600

Fred Walsh

Alex Price

Neil Shah

Luisa Orsini Baroni

Alma PR

(Financial PR)

Josh Royston

Susie Hudson

panoply@almapr.co.uk

+44(0)203 405 0206

07780 901979

About The Panoply

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology and innovation consulting businesses across Europe, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

www.thepanoply.com 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTLLFEREVITIIA
Date   Source Headline
1st Jun 20267:00 amRNSTPXimpact announces £16m contract with the MoJ
11th May 20267:00 amRNSShare Incentive Plan
22nd Apr 20267:00 amRNSFull Year Trading Update and Notice of Results
17th Apr 20264:17 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSShare Incentive Plan
20th Mar 20267:00 amRNSShare Incentive Plan
24th Feb 20267:00 amRNSQ3 Trading Update: EBITDA guidance Upgrade
17th Feb 20267:00 amRNSContract Uplift
12th Feb 20267:01 amRNSTPXimpact announces £39m Contract with DEFRA
12th Feb 20267:00 amRNSShare Incentive Plan
11th Feb 20267:00 amRNSTPXimpact announces £22m NHS England contract
9th Jan 20267:00 amRNSShare Incentive Plan
9th Dec 20257:00 amRNSShare Incentive Plan
8th Dec 20255:19 pmRNSHolding(s) in Company
2nd Dec 20252:45 pmRNSExercise of Options, PDMR, & Total Voting Rights
2nd Dec 20257:00 amRNSUnaudited Interim Results
24th Nov 20257:30 amRNSAppointment of Nominated Adviser and Broker
14th Nov 20257:00 amRNSShare Incentive Plan
5th Nov 20257:00 amRNSFirst Half Update & Notice of Results
14th Oct 20255:29 pmRNSShare Incentive Plan
25th Sep 20254:37 pmRNSResult of AGM
9th Sep 20257:00 amRNSShare Incentive Plan
8th Sep 20255:25 pmRNSExercise of Options & PDMR Dealings
8th Sep 20253:27 pmRNSNotification of Major Holdings
5th Sep 202512:37 pmRNSIssuance of Shares & Total Voting Rights
22nd Aug 20257:00 amRNSNotice of AGM
21st Aug 20257:00 amRNSChange of Auditor
12th Aug 20256:05 pmRNSReplacement: FY25 & FY26 Share Awards
11th Aug 20257:00 amRNSPosting of Annual Report
4th Aug 20259:24 amRNSReplacement: FY25 & FY26 Share Awards
4th Aug 20257:00 amRNSFY25 & FY26 Long-Term Incentive Share Award
30th Jul 20257:00 amRNSDebt Facility Renewal Update
14th Jul 20257:00 amRNSAppointment of non-executive director
10th Jul 20257:00 amRNSShare Incentive Plan
24th Jun 20257:00 amRNSUnaudited preliminary results
16th Jun 20259:00 amRNSNotice of Results
12th Jun 20251:17 pmRNSShare Incentive Plan
14th May 20257:00 amRNSTrading Update and Contract Wins
22nd Apr 20257:00 amRNSResignation of Non-Executive Director
11th Apr 20257:00 amRNSShare Incentive Plan
12th Mar 20257:00 amRNSShare Incentive Plan
28th Feb 20253:26 pmRNSChange of Registered Office Address
12th Feb 20257:00 amRNSShare Incentive Plan
6th Feb 20257:00 amRNSQ3 Trading Update and Revised Outlook
3rd Feb 20257:00 amRNSConfirmation of CFO Appointment
15th Jan 20257:00 amRNSShare Incentive Plan
18th Dec 20247:00 amRNSDirectorate Change - Group CFO retirement
11th Dec 20247:00 amRNSShare Incentive Plan
5th Dec 20247:00 amRNSExercise of Options and PDMR Dealings
28th Nov 20247:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.